Zydus and Guardant Health Support LiS Academy for Cancer Care Awareness

ZydusLifesciences Ltd., a global innovation driven healthcarecompanyandGuardantHealth,aleadingprecisiononcologycompany,announced their support for the newly launched Liquid is Solid® (LiS)Academy’s educational effort.

Establishedanddrivenby leadingoncologists,theLiSacademy isanindependent academic forumandafirst-of-its-kindinitiativeinIndia,whichisfocusedonincreasingtheawarenessof precisionmedicineusingliquidbiopsies(minimallyinvasiveblood-basedtests)intransforming cancer care.

"Precision medicine and liquid biopsy represent the future of oncology. However, without widespread awareness, its potential remains untapped," said Dr. T. Raja, Sr consultant &Director of Medical Oncology at Apollo Cancer Centre Chennai. "LiS Academy aims to bridge this gap by equipping doctors with the knowledge and resources needed to implement liquid biopsies effectively in cancer care and empower patients with increased awareness.”

With one in nine people likely to develop cancer in his or her lifetime in India1, cutting-edge diagnostic solutions can play a critical role in reducing the burden of cancer by helping clinicianstodetectcancerearly,monitorrecurrenceandidentifytargetedtreatmentstrategies with a simple blood draw.

"Ourfocusinoncologycareistohelppatientsthroughaholisticapproachrightfromaccessing affordabletherapies,tocompaniondiagnostics,nutritionandcounselling.TheaimthroughLiS Academy is to support clinicians and bring in a greater understanding and awareness on precision oncology and enable better patient care." saidSamir Desai, President, BU Biologics, Zydus Lifesciences Limited. "By fostering collaboration between clinicians, researchers, and industry leaders, we can accelerate the adoption of these life-saving technologies."

"The launch of LiS Academy marks a pivotal step in bringing transformative cancer care to India. By empowering oncologists with the awareness of liquid biopsies, we can accelerate accesstopersonalisedtreatmentandimproveoutcomesformorepatientsacross thecancer continuuminIndia,"saidSimranjitSingh,CEOofGuardantHealthAMEA."Wearecommitted to fostering a future where healthcare is data-driven and patient-centric."

"Structured programs through the LiS Academy provide clinicians with a solid foundation in understanding and utilising liquid biopsy technologies," said Dr. Nitesh Rohatgi,Senior Director Medical Oncology at Fortis Memorial Research Institute, Gurugram. "Peer mentoring also ensures that the learning goes beyond theoretical knowledge, empowering doctors to confidently integrate these innovations into their practice and improve patient outcomes.”

Withcancerincidencesontherise,thecontinuousefforttobridgeknowledgegapswhichlimit healthcare innovations is paramount.